Patient in the second dose group of IMM01 project continued to benefit

...

2020-04-15

The second dose group clinical trial of IMM01 project was successfully completed

...

2020-03-26

2020 Annual Conference

The annual celebration of the 2019 Annual Conference ended smoothly. Thank all colleagues of the company for their hard work and dedication in the past year! Work Work Hard，Day Day Up! Happy New Year to you! ...

2020-01-19

ImmuneOnco was awarded Star Light List-2019 China's Top 50 Biopharmaceutical Enterprises with the Most Innovative Ability

On August 4, 2019, ImmuneOnco won the award of Star Light List - the top 50 innovative enterprises of China's biomedical enterprises in 2019. The selection was made by enterprises in the field of bio-innovative drugs from the front line of the country, incl......

2019-08-06

Conference on Phase I Clinical Trial Scheme of ImmuneOnco IMM0306 Project solemnly held

...

2019-08-05